Skip to main content
. 2017 Feb 28;31(4):289–305. doi: 10.1007/s40263-017-0415-2

Fig. 4.

Fig. 4

Mean percentage change in BV (measured with SIENA) from baseline in the 2-year FREEDOMS trial, in subgroups of patients with and without gadolinium-enhancing lesions at baseline [35]. BV brain volume, Gd+ gadolinium-enhancing, SIENA Structural Image Evaluation, using Normalization, of Atrophy; *p < 0.05, **p < 0.01, ***p < 0.001 versus placebo